325 related articles for article (PubMed ID: 22830357)
21. Phytochemical regulation of the tumor suppressive microRNA, miR-34a, by p53-dependent and independent responses in human breast cancer cells.
Hargraves KG; He L; Firestone GL
Mol Carcinog; 2016 May; 55(5):486-98. PubMed ID: 25789847
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
23. Myc overexpression brings out unexpected antiapoptotic effects of miR-34a.
Sotillo E; Laver T; Mellert H; Schelter JM; Cleary MA; McMahon S; Thomas-Tikhonenko A
Oncogene; 2011 Jun; 30(22):2587-94. PubMed ID: 21297663
[TBL] [Abstract][Full Text] [Related]
24. miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy.
Nakatani F; Ferracin M; Manara MC; Ventura S; Del Monaco V; Ferrari S; Alberghini M; Grilli A; Knuutila S; Schaefer KL; Mattia G; Negrini M; Picci P; Serra M; Scotlandi K
J Pathol; 2012 Apr; 226(5):796-805. PubMed ID: 21960059
[TBL] [Abstract][Full Text] [Related]
25. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
[TBL] [Abstract][Full Text] [Related]
26. p53 represses c-Myc through induction of the tumor suppressor miR-145.
Sachdeva M; Zhu S; Wu F; Wu H; Walia V; Kumar S; Elble R; Watabe K; Mo YY
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3207-12. PubMed ID: 19202062
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation.
Li Y; Challagundla KB; Sun XX; Zhang Q; Dai MS
Oncotarget; 2015 Jan; 6(2):1101-14. PubMed ID: 25544755
[TBL] [Abstract][Full Text] [Related]
28. Hypofractionated radiotherapy induces miR-34a expression and enhances apoptosis in human nasopharyngeal carcinoma cells.
Long Z; Wang B; Tao D; Huang Y; Tao Z
Int J Mol Med; 2014 Nov; 34(5):1388-94. PubMed ID: 25231528
[TBL] [Abstract][Full Text] [Related]
29. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop.
Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S
Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179
[TBL] [Abstract][Full Text] [Related]
30. Differential microRNA-34a expression and tumor suppressor function in retinoblastoma cells.
Dalgard CL; Gonzalez M; deNiro JE; O'Brien JM
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4542-51. PubMed ID: 19443717
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
[TBL] [Abstract][Full Text] [Related]
32. A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.
Kong LM; Liao CG; Zhang Y; Xu J; Li Y; Huang W; Zhang Y; Bian H; Chen ZN
Cancer Res; 2014 Jul; 74(14):3764-78. PubMed ID: 24906624
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma.
Yamamura S; Saini S; Majid S; Hirata H; Ueno K; Chang I; Tanaka Y; Gupta A; Dahiya R
Carcinogenesis; 2012 Feb; 33(2):294-300. PubMed ID: 22159222
[TBL] [Abstract][Full Text] [Related]
34. SIRT1 inhibition restores apoptotic sensitivity in p53-mutated human keratinocytes.
Herbert KJ; Cook AL; Snow ET
Toxicol Appl Pharmacol; 2014 Jun; 277(3):288-97. PubMed ID: 24726431
[TBL] [Abstract][Full Text] [Related]
35. MiR-23a-mediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma.
Wang N; Zhu M; Tsao SW; Man K; Zhang Z; Feng Y
Mol Cancer; 2013 Oct; 12(1):119. PubMed ID: 24103454
[TBL] [Abstract][Full Text] [Related]
36. Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Rajkumar KS; Rajaraman R; Munirajan AK
Asian Pac J Cancer Prev; 2015; 16(17):7619-25. PubMed ID: 26625772
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
[TBL] [Abstract][Full Text] [Related]
38. Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells.
Chakraborty S; Mazumdar M; Mukherjee S; Bhattacharjee P; Adhikary A; Manna A; Chakraborty S; Khan P; Sen A; Das T
FEBS Lett; 2014 Feb; 588(4):549-59. PubMed ID: 24444609
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-induced decrease in p53 protein level and increase in c-jun DNA binding activity results in cancer cell resistance to etoposide.
Cosse JP; Ronvaux M; Ninane N; Raes MJ; Michiels C
Neoplasia; 2009 Oct; 11(10):976-86. PubMed ID: 19794957
[TBL] [Abstract][Full Text] [Related]
40. MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms.
Kojima K; Fujita Y; Nozawa Y; Deguchi T; Ito M
Prostate; 2010 Oct; 70(14):1501-12. PubMed ID: 20687223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
